Next 10 |
2024-04-19 17:10:14 ET More on ContraVir Seeking Alpha’s Quant Rating on ContraVir Historical earnings data for ContraVir Financial information for ContraVir Read the full article on Seeking Alpha For further details see: Hepion ends Phase ...
2024-04-09 10:03:48 ET More on Madrigal Pharmaceuticals Madrigal: Accelerated Rezdiffra Approval Puts It In The NASH Lead Madrigal Wins The 'MASH Dash' And A Chance To Shape The Market Before GLP-1 Challenge Madrigal Pharmaceuticals: Perceived Threat From Eli Lilly I...
2024-03-28 11:27:08 ET Inventiva S.A. (IVA) Q4 2023 Results Conference Call March 28, 2024 08:00 AM ET Company Participants Frederic Cren - CEO Jean Volatier - CFO Conference Call Participants Seamus Fernandez - Guggenheim Securities Rami Katkhuda - L...
2024-03-27 16:06:34 ET More on Inventiva Inventiva: Biotech To Consider Despite Short NASH Study Enrollment Pause Inventiva Phase 2 study for MASH drug meets primary endpoint Inventiva resumes Phase 3 study for NASH drug, stock up 6% Seeking Alpha’s Qu...
Cano Health Inc. Class A (CANOQ) is expected to report for Q4 2023 Cathay Pacific Airways Ltd. ADR (CPCAY) is expected to report for Q4 2023 NeuroSense Therapeutics Ltd. (NRSN) is expected to report for quarter end 2023-12-31 Bayerische Motoren Werke AG (BAMXF) is expected to report f...
2024-03-19 08:44:21 ET More on Pre-market losers & stocks. Coinbase: My Pick For The Most Overvalued U.S. Stock Coinbase Global Inc (COIN) Morgan Stanley Technology, Media and Telecom Conference (Transcript) Coinbase: A Crypto Play With A Catalyst (Rating Upgrade...
2024-03-18 17:45:43 ET More on Inventiva Inventiva: Biotech To Consider Despite Short NASH Study Enrollment Pause Inventiva resumes Phase 3 study for NASH drug, stock up 6% Inventiva drops after adverse event in Phase 3 trial for NASH drug Seeking Alphaȁ...
2024-03-18 16:38:49 ET Gainers: National CineMedia ( NCMI ) +8% . Inventiva ( IVA ) +6% . Alpine Immune Sciences ( ALPN ) +5% . Leslie's ( LESL ) +5% . Maxeon Solar Technologies ( MAXN ) +5% . Losers: DLocal ( DLO...
2024-03-16 12:57:30 ET More on Madrigal Pharmaceuticals Madrigal Wins The 'MASH Dash' And A Chance To Shape The Market Before GLP-1 Challenge Madrigal Pharmaceuticals: Perceived Threat From Eli Lilly Is Overblown Madrigal's MASH Dilemma: Eli Lilly Enters The Fray (Ra...
2024-03-15 08:19:55 ET More on Madrigal Pharmaceuticals Madrigal Pharmaceuticals: Perceived Threat From Eli Lilly Is Overblown Madrigal's MASH Dilemma: Eli Lilly Enters The Fray (Rating Downgrade) Madrigal Pharmaceuticals: Eli Lilly's NASH Data Threatens Resmetirom's...
News, Short Squeeze, Breakout and More Instantly...
Inventiva S.A. Company Name:
IVA Stock Symbol:
NASDAQ Market:
Daix (France), Long Island City (New York, United States), April 3, 2024 – Inventiva (NASDAQ:IVA) (the "Company"), a clinical-stage biopharmaceu...
Daix (France), Long Island City (New York, United States), March 28, 2024 – Inventiva (NASDAQ:IVA) (the "Company"), a clinical-stage biopharmace...
Revenues at €17.5 million for the full year of 2023 up 43.4% compared to €12.2 million for 2022 Cash and cash equivalents at €26.9 millio...